154 related articles for article (PubMed ID: 11980714)
1. Inactivation of Cdc7 kinase in mouse ES cells results in S-phase arrest and p53-dependent cell death.
Kim JM; Nakao K; Nakamura K; Saito I; Katsuki M; Arai K; Masai H
EMBO J; 2002 May; 21(9):2168-79. PubMed ID: 11980714
[TBL] [Abstract][Full Text] [Related]
2. Functions of mammalian Cdc7 kinase in initiation/monitoring of DNA replication and development.
Kim JM; Yamada M; Masai H
Mutat Res; 2003 Nov; 532(1-2):29-40. PubMed ID: 14643427
[TBL] [Abstract][Full Text] [Related]
3. Functional analyses of mouse ASK, an activation subunit for Cdc7 kinase, using conditional ASK knockout ES cells.
Yamashita N; Kim JM; Koiwai O; Arai K; Masai H
Genes Cells; 2005 Jun; 10(6):551-63. PubMed ID: 15938714
[TBL] [Abstract][Full Text] [Related]
4. Cdc7 inhibition reveals a p53-dependent replication checkpoint that is defective in cancer cells.
Montagnoli A; Tenca P; Sola F; Carpani D; Brotherton D; Albanese C; Santocanale C
Cancer Res; 2004 Oct; 64(19):7110-6. PubMed ID: 15466207
[TBL] [Abstract][Full Text] [Related]
5. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
6. Growth regulation of the expression of mouse cDNA and gene encoding a serine/threonine kinase related to Saccharomyces cerevisiae CDC7 essential for G1/S transition. Structure, chromosomal localization, and expression of mouse gene for s. cerevisiae Cdc7-related kinase.
Kim JM; Sato N; Yamada M; Arai K; Masai H
J Biol Chem; 1998 Sep; 273(36):23248-57. PubMed ID: 9722556
[TBL] [Abstract][Full Text] [Related]
7. High levels of Cdc7 and Dbf4 proteins can arrest cell-cycle progression.
Guo B; Romero J; Kim BJ; Lee H
Eur J Cell Biol; 2005 Dec; 84(12):927-38. PubMed ID: 16325502
[TBL] [Abstract][Full Text] [Related]
8. Cdc7 kinase complex: a key regulator in the initiation of DNA replication.
Masai H; Arai K
J Cell Physiol; 2002 Mar; 190(3):287-96. PubMed ID: 11857444
[TBL] [Abstract][Full Text] [Related]
9. Hypomorphic mutation in an essential cell-cycle kinase causes growth retardation and impaired spermatogenesis.
Kim JM; Takemoto N; Arai K; Masai H
EMBO J; 2003 Oct; 22(19):5260-72. PubMed ID: 14517263
[TBL] [Abstract][Full Text] [Related]
10. Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine.
Gollapudi L; Neet KE
J Neurosci Res; 1997 Aug; 49(4):461-74. PubMed ID: 9285522
[TBL] [Abstract][Full Text] [Related]
11. Regulation of DNA replication during the cell cycle: roles of Cdc7 kinase and coupling of replication, recombination, and repair in response to replication fork arrest.
Masai H; Arai K
IUBMB Life; 2000 May; 49(5):353-64. PubMed ID: 10902566
[TBL] [Abstract][Full Text] [Related]
12. Genetic dissection of mammalian Cdc7 kinase: cell cycle and developmental roles.
Kim JM; Masai H
Cell Cycle; 2004 Mar; 3(3):300-4. PubMed ID: 14726652
[TBL] [Abstract][Full Text] [Related]
13. Targeting cell division cycle 7 kinase: a new approach for cancer therapy.
Montagnoli A; Moll J; Colotta F
Clin Cancer Res; 2010 Sep; 16(18):4503-8. PubMed ID: 20647475
[TBL] [Abstract][Full Text] [Related]
14. p53-dependent signaling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts.
Cistulli CA; Kaufmann WK
Cancer Res; 1998 May; 58(9):1993-2002. PubMed ID: 9581844
[TBL] [Abstract][Full Text] [Related]
15. Suppression of replication fork progression in low-dose-specific p53-dependent S-phase DNA damage checkpoint.
Shimura T; Toyoshima M; Adiga SK; Kunoh T; Nagai H; Shimizu N; Inoue M; Niwa O
Oncogene; 2006 Sep; 25(44):5921-32. PubMed ID: 16682953
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
[TBL] [Abstract][Full Text] [Related]
17. Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor.
Erker L; Schubert R; Yakushiji H; Barlow C; Larson D; Mitchell JB; Wynshaw-Boris A
Hum Mol Genet; 2005 Jun; 14(12):1699-708. PubMed ID: 15888486
[TBL] [Abstract][Full Text] [Related]
18. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
19. A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint.
Rohaly G; Chemnitz J; Dehde S; Nunez AM; Heukeshoven J; Deppert W; Dornreiter I
Cell; 2005 Jul; 122(1):21-32. PubMed ID: 16009130
[TBL] [Abstract][Full Text] [Related]
20. Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers.
Rodriguez-Acebes S; Proctor I; Loddo M; Wollenschlaeger A; Rashid M; Falzon M; Prevost AT; Sainsbury R; Stoeber K; Williams GH
Am J Pathol; 2010 Oct; 177(4):2034-45. PubMed ID: 20724597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
